Revision as of 01:28, 18 July 2023 edit Jtelser (talk \| contribs) 269 edits m ~~~~ corrected initial academic position based on web site https://chemistry.berkeley.edu/faculty/chem/marletta ← Previous edit		Latest revision as of 01:31, 18 July 2023 edit undo Jtelser (talk \| contribs) 269 edits m ~~~~ corrected name of his chair: "Marletta is the C.H. and Annie Li Chair in the Molecular Biology of Diseases" - not "Ch"
Line 30: He was a [[Howard Hughes Medical Institute]] Investigator.<ref>[http://www.hhmi.org/research/investigators/marletta_bio.html Investigator (Alumni) Michael A. Marletta, Ph.D. \| Howard Hughes Medical Institute]. HHMI. Retrieved on 2013-10-08.</ref> From January 2012 to August 2014, Marletta was president and CEO of [[The Scripps Research Institute]] in [[La Jolla, California]], succeeding [[Richard Lerner]].<ref>[http://www.scripps.edu/news/press/20110220.html The Scripps Research Institute Names Michael A. Marletta as President]. Scripps.edu (2011-02-20).</ref> Marletta is currently ChC. H. and Annie Li Chair in the Molecular Biology of Diseases at the University of California, Berkeley.<ref>[http://vcresearch.berkeley.edu/faculty/michael-marletta Michael A. Marletta]. chem.berkeley.edu</ref> In 2009, Marletta helped [[Jennifer Doudna]] return to UC Berkeley after working a short stint at [[Genentech]];<ref>{{Cite book\|last=Isaacson\|first=Walter\|title=[[The Code Breaker]]\|publisher=[[Simon & Schuster]]\|year=2021\|isbn=978-1-9821-1585-2\|pages=101\|author-link=Walter Isaacson}}</ref> Doudna would later win the 2020 [[Nobel Prize in Chemistry]] with [[Emmanuelle Charpentier]] for her work on [[CRISPR]] after returning to UC Berkeley from Genentech. ==Awards==

Michael Marletta: Difference between revisions